Anthrax, Bioterrorism Fears Stimulate Immune, Other Research

AIDS TREATMENT NEWS Issue #373, October 26, 2001
John S. James


A November 7 press report ("All-Purpose Drugs Are Being Tested," by Jeff Donn, The Associated Press) surveyed some of the work being done on finding drugs to treat many diseases -- the opposite of the traditional "magic bullet" approach of targeting only one particular bacterium or virus. Many of these "all purpose" potential drugs work by strengthening the immune system -- especially innate immunity, which is less well understood that the more familiar "adaptive" immunity involving T-cells (with which the body quickly produces a customized response to a particular invader, hopefully in time to cure the illness). Invertebrate animals survive and fight infection with only innate immunity.

Some of the approaches now being studied have long been used in traditional or "alternative" medical treatments. Others are far from ready for human test.

The AP story mentions:

* Certain cytokines and peptidoglycans that may stimulate natural immunity. These approaches are being examined as possible defenses against bioterrorism, including anthrax or smallpox. If they work, they might have great impact on more routine medical practice as well.

* "Androstene steroids" to block the action of cortisone (according to the reporter's writeup, which we have not yet checked further).

* Ways to correct the immune-system damage caused by exposure to nuclear radiation. Success here might lead to ways of strengthening the immune system in HIV, malaria, and other diseases.

* A drug that acts like the popular supplement NAC (N- acetylcysteine) may help treat certain bacterial toxins, by reducing free-radical damage.

* Old remedies based on silver are now getting scientific study, after one consistently worked as well as tetracycline in laboratory tests against certain bacteria.

The new focus on bioterrorism will greatly stimulate research on immune-based treatments, neglected traditional medical approaches, and on completely new approaches as well. It will bring in new people and resources, and move with urgency and serious support -- no longer at the leisurely pace of academic medical journals, or under the commercial short-term focus on already-proven profit areas. Here is the urgency we have long sought but seldom found. The AIDS community should pay close attention.

011026
ATN37304


Copyright © 2001 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org  http://www.aidsnews.org

Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Feedback/Contact Us.